APA (7th ed.) Citation

Ratcliffe, P., Adam, J. M., Baker, J., Bursi, R., Campbell, R., Clark, J. K., . . . Morrison, A. (2011). Design, synthesis and structure–activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate. Bioorganic & Medicinal Chemistry Letters, 21(8), 2541. https://doi.org/10.1016/j.bmcl.2011.02.023

Chicago Style (17th ed.) Citation

Ratcliffe, Paul, et al. "Design, Synthesis and Structure–activity Relationships of (indo-3-yl) Heterocyclic Derivatives as Agonists of the CB1 Receptor. Discovery of a Clinical Candidate." Bioorganic & Medicinal Chemistry Letters 21, no. 8 (2011): 2541. https://doi.org/10.1016/j.bmcl.2011.02.023.

MLA (9th ed.) Citation

Ratcliffe, Paul, et al. "Design, Synthesis and Structure–activity Relationships of (indo-3-yl) Heterocyclic Derivatives as Agonists of the CB1 Receptor. Discovery of a Clinical Candidate." Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 8, 2011, p. 2541, https://doi.org/10.1016/j.bmcl.2011.02.023.